AGONIST TO HUMAN beta3 ADRENALINE RECEPTOR
It is intended to provide an agonist to human beta3 adrenaline receptor originating in a natural substance which is a safe material having taken by humans, and a drug for preventing and/or ameliorating life style-related diseases such as fatness, obesity, diabetes, hyperlipemia, hypertension and gou...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KAWATA, TERUO TSUKAGAWA, MISUZU MAE, TATSUMASA |
| description | It is intended to provide an agonist to human beta3 adrenaline receptor originating in a natural substance which is a safe material having taken by humans, and a drug for preventing and/or ameliorating life style-related diseases such as fatness, obesity, diabetes, hyperlipemia, hypertension and gout. Namely, an agonist to human beta3 adrenaline receptor which comprises, as the active ingredient, at least one substance selected from among Tropaeolum majus extract, Dioscorea batatas extract, Cyperaceae Scirpus yagara extract and Tinospora capillipes Gagnep. extract. This agonist to human beta3 adrenaline receptor is efficacious as a drug for preventing and/or ameliorating life style-related diseases such as fatness, obesity, diabetes, hyperlipemia, hypertension and gout.
L'intention est de fournir un agoniste vis-à-vis du récepteur beta3 humain de l'adrénaline trouvant son origine dans une substance naturelle qui est une matière sans danger prise par les êtres humains et un médicament pour prévenir et/ou améliorer des maladies liées au mode de vie telles que l'embonpoint, l'obésité, les diabètes, l'hyperlipémie, l'hypertension et la goutte. A savoir, agoniste vis-à-vis du récepteur beta3 humain de l'adrénaline lequel comprend, comme ingrédient actif, au moins une substance choisie parmi de l'extrait de Tropaeolum majus, de l'extrait de Dioscorea batatas, de l'extrait de Cyperaceae Scirpus yagara et de l'extrait de Tinospora capillipes Gagnep. Cet agoniste vis-à-vis du récepteur beta3 humain de l'adrénaline est efficace comme médicament pour prévenir et/ou améliorer des maladies liées au mode de vie telles que l'embonpoint, l'obésité, les diabètes, l'hyperlipémie, l'hypertension et la goutte. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2005082391A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2005082391A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2005082391A13</originalsourceid><addsrcrecordid>eNrjZNBydPf38wwOUQjxV_AI9XX0U0hKLUk0VnB0CXL1c_Tx9HNVCHJ1dg0I8Q_iYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBgamBhZGxpaGjobGxKkCAAGqJdQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>AGONIST TO HUMAN beta3 ADRENALINE RECEPTOR</title><source>esp@cenet</source><creator>KAWATA, TERUO ; TSUKAGAWA, MISUZU ; MAE, TATSUMASA</creator><creatorcontrib>KAWATA, TERUO ; TSUKAGAWA, MISUZU ; MAE, TATSUMASA</creatorcontrib><description>It is intended to provide an agonist to human beta3 adrenaline receptor originating in a natural substance which is a safe material having taken by humans, and a drug for preventing and/or ameliorating life style-related diseases such as fatness, obesity, diabetes, hyperlipemia, hypertension and gout. Namely, an agonist to human beta3 adrenaline receptor which comprises, as the active ingredient, at least one substance selected from among Tropaeolum majus extract, Dioscorea batatas extract, Cyperaceae Scirpus yagara extract and Tinospora capillipes Gagnep. extract. This agonist to human beta3 adrenaline receptor is efficacious as a drug for preventing and/or ameliorating life style-related diseases such as fatness, obesity, diabetes, hyperlipemia, hypertension and gout.
L'intention est de fournir un agoniste vis-à-vis du récepteur beta3 humain de l'adrénaline trouvant son origine dans une substance naturelle qui est une matière sans danger prise par les êtres humains et un médicament pour prévenir et/ou améliorer des maladies liées au mode de vie telles que l'embonpoint, l'obésité, les diabètes, l'hyperlipémie, l'hypertension et la goutte. A savoir, agoniste vis-à-vis du récepteur beta3 humain de l'adrénaline lequel comprend, comme ingrédient actif, au moins une substance choisie parmi de l'extrait de Tropaeolum majus, de l'extrait de Dioscorea batatas, de l'extrait de Cyperaceae Scirpus yagara et de l'extrait de Tinospora capillipes Gagnep. Cet agoniste vis-à-vis du récepteur beta3 humain de l'adrénaline est efficace comme médicament pour prévenir et/ou améliorer des maladies liées au mode de vie telles que l'embonpoint, l'obésité, les diabètes, l'hyperlipémie, l'hypertension et la goutte.</description><edition>7</edition><language>eng ; fre ; jpn</language><subject>FOODS OR FOODSTUFFS ; FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT ; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050909&DB=EPODOC&CC=WO&NR=2005082391A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050909&DB=EPODOC&CC=WO&NR=2005082391A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KAWATA, TERUO</creatorcontrib><creatorcontrib>TSUKAGAWA, MISUZU</creatorcontrib><creatorcontrib>MAE, TATSUMASA</creatorcontrib><title>AGONIST TO HUMAN beta3 ADRENALINE RECEPTOR</title><description>It is intended to provide an agonist to human beta3 adrenaline receptor originating in a natural substance which is a safe material having taken by humans, and a drug for preventing and/or ameliorating life style-related diseases such as fatness, obesity, diabetes, hyperlipemia, hypertension and gout. Namely, an agonist to human beta3 adrenaline receptor which comprises, as the active ingredient, at least one substance selected from among Tropaeolum majus extract, Dioscorea batatas extract, Cyperaceae Scirpus yagara extract and Tinospora capillipes Gagnep. extract. This agonist to human beta3 adrenaline receptor is efficacious as a drug for preventing and/or ameliorating life style-related diseases such as fatness, obesity, diabetes, hyperlipemia, hypertension and gout.
L'intention est de fournir un agoniste vis-à-vis du récepteur beta3 humain de l'adrénaline trouvant son origine dans une substance naturelle qui est une matière sans danger prise par les êtres humains et un médicament pour prévenir et/ou améliorer des maladies liées au mode de vie telles que l'embonpoint, l'obésité, les diabètes, l'hyperlipémie, l'hypertension et la goutte. A savoir, agoniste vis-à-vis du récepteur beta3 humain de l'adrénaline lequel comprend, comme ingrédient actif, au moins une substance choisie parmi de l'extrait de Tropaeolum majus, de l'extrait de Dioscorea batatas, de l'extrait de Cyperaceae Scirpus yagara et de l'extrait de Tinospora capillipes Gagnep. Cet agoniste vis-à-vis du récepteur beta3 humain de l'adrénaline est efficace comme médicament pour prévenir et/ou améliorer des maladies liées au mode de vie telles que l'embonpoint, l'obésité, les diabètes, l'hyperlipémie, l'hypertension et la goutte.</description><subject>FOODS OR FOODSTUFFS</subject><subject>FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT</subject><subject>THEIR TREATMENT, NOT COVERED BY OTHER CLASSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBydPf38wwOUQjxV_AI9XX0U0hKLUk0VnB0CXL1c_Tx9HNVCHJ1dg0I8Q_iYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBgamBhZGxpaGjobGxKkCAAGqJdQ</recordid><startdate>20050909</startdate><enddate>20050909</enddate><creator>KAWATA, TERUO</creator><creator>TSUKAGAWA, MISUZU</creator><creator>MAE, TATSUMASA</creator><scope>EVB</scope></search><sort><creationdate>20050909</creationdate><title>AGONIST TO HUMAN beta3 ADRENALINE RECEPTOR</title><author>KAWATA, TERUO ; TSUKAGAWA, MISUZU ; MAE, TATSUMASA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2005082391A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; jpn</language><creationdate>2005</creationdate><topic>FOODS OR FOODSTUFFS</topic><topic>FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT</topic><topic>THEIR TREATMENT, NOT COVERED BY OTHER CLASSES</topic><toplevel>online_resources</toplevel><creatorcontrib>KAWATA, TERUO</creatorcontrib><creatorcontrib>TSUKAGAWA, MISUZU</creatorcontrib><creatorcontrib>MAE, TATSUMASA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KAWATA, TERUO</au><au>TSUKAGAWA, MISUZU</au><au>MAE, TATSUMASA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>AGONIST TO HUMAN beta3 ADRENALINE RECEPTOR</title><date>2005-09-09</date><risdate>2005</risdate><abstract>It is intended to provide an agonist to human beta3 adrenaline receptor originating in a natural substance which is a safe material having taken by humans, and a drug for preventing and/or ameliorating life style-related diseases such as fatness, obesity, diabetes, hyperlipemia, hypertension and gout. Namely, an agonist to human beta3 adrenaline receptor which comprises, as the active ingredient, at least one substance selected from among Tropaeolum majus extract, Dioscorea batatas extract, Cyperaceae Scirpus yagara extract and Tinospora capillipes Gagnep. extract. This agonist to human beta3 adrenaline receptor is efficacious as a drug for preventing and/or ameliorating life style-related diseases such as fatness, obesity, diabetes, hyperlipemia, hypertension and gout.
L'intention est de fournir un agoniste vis-à-vis du récepteur beta3 humain de l'adrénaline trouvant son origine dans une substance naturelle qui est une matière sans danger prise par les êtres humains et un médicament pour prévenir et/ou améliorer des maladies liées au mode de vie telles que l'embonpoint, l'obésité, les diabètes, l'hyperlipémie, l'hypertension et la goutte. A savoir, agoniste vis-à-vis du récepteur beta3 humain de l'adrénaline lequel comprend, comme ingrédient actif, au moins une substance choisie parmi de l'extrait de Tropaeolum majus, de l'extrait de Dioscorea batatas, de l'extrait de Cyperaceae Scirpus yagara et de l'extrait de Tinospora capillipes Gagnep. Cet agoniste vis-à-vis du récepteur beta3 humain de l'adrénaline est efficace comme médicament pour prévenir et/ou améliorer des maladies liées au mode de vie telles que l'embonpoint, l'obésité, les diabètes, l'hyperlipémie, l'hypertension et la goutte.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; jpn |
| recordid | cdi_epo_espacenet_WO2005082391A1 |
| source | esp@cenet |
| subjects | FOODS OR FOODSTUFFS FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT THEIR TREATMENT, NOT COVERED BY OTHER CLASSES |
| title | AGONIST TO HUMAN beta3 ADRENALINE RECEPTOR |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T23%3A16%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KAWATA,%20TERUO&rft.date=2005-09-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2005082391A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |